Olive oil may prevent the development of bowel cancer

January 24, 2000

[Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E2 synthesis] 2000: 46 191-9

Olive oil may protect against bowel cancer, finds a study in Gut based on research conducted in rats. Previous research has shown that dietary fat helps to promote cancer, but that the development of malignancy is associated both with the amount and type of fat consumed.

Over 100 rats were divided into three equal groups to be fed diets rich in either safflower oil containing n6 fatty acids, fish oil containing n3 fatty acids, or olive oil containing n9 fatty acids. Each of the three groups was then further divided, and one half given a cancer inducing agent. Evidence of precursors to malignancy, numbers of tumours, and the fatty acid content of bowel tissue were all assessed up to 19 weeks after the start of the diets.

Rats fed the safflower oil diet had more precancerous tissue - aberrant crypt foci and polyps - and more tumours than rats fed either the fish or olive oil diets. These last two diets also reduced the amount of arachidonate, a chemical involved in the synthesis of an inflammatory substance called prostaglandin E, which, experimental evidence shows, promotes cancer formation. The amount of this substance was significantly increased in the rats given the cancer inducing agent and the safflower diet, but not in those fed either the fish or olive oil diets.

Olive oil contains 75 per cent oleic acid. Oleic acid is also found in beef and poultry and in other vegetable oils, such as corn, soybean, and sunflower seed oil, although in lesser amounts. Because the other fats and oils contained in these foods actually promote cancer, it is unlikely that oleic acid alone accounts for the beneficial effects of olive oil, say the authors. Rather, they suggest that the other constituents of olive oil, such as squalene, flavonoids, and polyphenols, are likely to protect against cancer.
-end-
Contact: Professor Miguel Gassull, Department of Gastroenterology, University Hospital Germans Trias Pujol, Barcelona, Spain. mgassull@ns.hugtip.scs.es

BMJ Specialty Journals

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.